Chronic pain teaches you to gamble with yourself. There’s always one more treatment, one more possible cure, one more ...

The next step in the evolution of generative AI technology will rely on ‘world models’ to improve physical outcomes in the ...

Caliway Biopharmaceuticals (TWSE: 6919) today announced that it has completed the submission of an Investigational New Drug (IND) application to the U.S. FDA for a Phase 2 clinical study of its ...

This presentation outlines the key technology trends defining CES 2026, contextualised by the current global and US economic ...

Oncology and tackling chronic issues like obesity are still the big drivers for growth in the biotech world. Combining ...

GLP-1 usage is on the rise, and researchers are looking for other health benefits associated with the drug, including its effects on bladder health. But as GLP-1s rise in popularity, so do nicknames ...

The world’s first GLP-1 weight loss treatment is being administered for pets on an experimental basis. The first cat was successfully dosed in the MEOW-1 study of OKV-119 – an investigational ...

Jess Loren remembers loving the taste of Cap'n Crunch cereal. Coca-Cola. Snickers bars. But now, instead of a sweetness, "they taste bland," she says. Flavors are noticeably muted since she started a ...

Despite previous excitement around a potential link between GLP-1 drugs and a reduced risk of cancer, new research suggests the popular medications “probably have little or no effect” on a person’s ...

GLP-1 weight loss drugs have taken the food industry by storm. The drugs, which reduce “food noise”, the desire to eat, and increase feelings of fullness, are seen by some as an existential risk to ...

There’s trouble brewing beneath the GLP-1 buzz. As Americans embrace blockbuster weight-loss drugs like Ozempic and Wegovy in record numbers, providers are warning of a troubling ripple effect: ...